Concepedia

Salma K. Jabbour

SK

105

Publications

7.4K

Citations

40

H-Index

1995

Active since

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Johnson University

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Salma K. Jabbour is an author at Rutgers, The State University of New Jersey specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1995–2024

105

Publications

105

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +11

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI

Ke Nie, Liming Shi, Qin Chen et al. · Clinical Cancer Research · 2016 · 427 citations · Full text

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

Matteo Palmeri, Janice M. Mehnert, Ann W. Silk et al. · ESMO Open · 2021 · 333 citations · Full text

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer

Salma K. Jabbour, Ki Hyeong Lee, Nikolaj Frost et al. · JAMA Oncology · 2021 · 231 citations · Full text

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

Jonathan D. Schoenfeld, Anita Giobbie‐Hurder, Srinika Ranasinghe et al. · The Lancet Oncology · 2022 · 225 citations · Full text

, , +5

Rows per page

1–5 of 105